Allergy Diagnostics Market is Projected to be Worth US$ 3.8 Billion by 2024
The consumables segment accounted for the major share in the allergy diagnostics market. The segment is projected to present a 50.1% share by 2024, registering the highest CAGR of 13.6% during the forecast period. The instruments segment, on the other hand, is projected to witness sluggish growth through 2024. By allergen type, the inhaled allergens segment accounted for the dominant share in the allergy diagnostics market, with the food allergens segment expected to register a high CAGR from 2016 to 2024.
Read Report Overview @ https://www.transparencymarketresearch.com/allergy-diagnostics-market.html
Based on test, in vivo tests led the market while in vitro tests present the most attractive growth opportunities. Diagnostic laboratories are the leading end users of allergy diagnostics and are also likely to exhibit the strongest growth during the course of the forecast period.
Taking the lead from a geographical standpoint, North America is forecast to account for 39.9% of the global allergy diagnostics market by 2024. On the other hand, Asia Pacific will register the most promising CAGR of 13.6% during the forecast period.
Apart from the growing prevalence of allergies across the globe, the allergy diagnostics market is fueled by a number of genetic, geographical, social, and economic factors.
A theory key to the development of the allergy diagnostics market is the “hygiene hypothesis”. This hypothesis states that the lack of early exposure to infectious agents and microorganisms increases the susceptibility of a person to allergies, by restricting the early development of the immune system. According to the theory, the urban and western lifestyle, with its limited exposure to infectious agents in childhood, is highly responsible for the increased prevalence of allergies in countries in the West. Supporting this theory are statistics revealed by the Global Burden of Asthma. In 2013, figures showed that the U.S., Australia, New Zealand, and the U.K. had a 20 times higher prevalence of allergies than other countries. This, in turn, has been driving the demand for allergy diagnostics in these countries.
An alarming rise in pollution levels, genetic factors responsible for the proneness to allergies, the availability of advanced technologies for allergy diagnostics, and increased healthcare expenditure worldwide are also contributing toward the growth of the allergy diagnostics market.
The global allergy diagnostics market is immensely consolidated, with the top five players accounting for around 73.0% in 2015. Thermo Fisher Scientific Inc., Quest Diagnostics, Inc., BioMerieux, Omega Diagnostics Group Plc., and Stallergenes Greer dominated the global market that year. Transparency Market Research notes that the market for allergy diagnostics displays intense rivalry among existing players owing to the presence of several large global players and a few local companies.
Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5147
Collaborations with leading firms to enter new markets has been noted to be a successful growth strategy adopted by dominant players. A case in point would be Quest Diagnostics. Given the role of genetics in developing allergies, the company collaborated with AncestryDNA in August 2016 to help meet the rapidly growing consumer demand for genetic tests. This collaboration is likely to allow Quest Diagnostics to expand its product portfolio in the in-vitro testing segment.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release Allergy Diagnostics Market is Projected to be Worth US$ 3.8 Billion by 2024 here
News-ID: 831082 • Views: 305
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment
More Releases for Diagnostic
Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs
Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Global Dermatology Diagnostic Devices Market
https://www.qandqmarketresearch.com/report-sample/dermatology-diagnostic-devices-market-6 This report studies the global Dermatology Diagnostic Devices market status and forecast, categorizes the global Dermatology Diagnostic Devices market size value & volume by key players, type, application, and region. This report focuses on the top players in North America, Europe, AsiaPacific, South America, and Middle East & Africa. Dermatology diagnostic devices are used for treating and diagnosing skin disorders. These devices assist in early detection of skin disorders and improving
Cervical Cancer Diagnostic Tests Market
A new market research report has been recently published by Transparency Market Research, a global market intelligence firm, and made available on the company website. The research study talks about the current scenario of global cervical cancer diagnosis tests market, along with the growth prospects of the market. The research study, titled “Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,”
Diagnostic Catheters Market 2017-2021
The latest industry research report on Diagnostic Catheters by MRC provides a thorough analysis of the global Diagnostic Catheters market. The report scrutinizes the market by different segments including regions, applications, competitive landscape, etc. over the predicted time frame. This report provides 360 Degree perspective of the Diagnostic Catheters industry with an all-inclusive discussion of definitions, classifications, and market players in the industry chain structure. It features qualitative and quantitative